HOME >> MEDICINE >> NEWS
AmericasDoctor.com & Affiliated Research Centers announce merger that revolutionizes clinical trial recruitment, expedites pharmaceutical research

Galen Associates, Tullis-Dickerson, Delphi Lead Investment Round; New Company is First 'Clicks & Mortar' Solution to Pharmaceutical Industry Needs

GURNEE, IL / OWINGS MILLS, MD (January 10, 2000) AmericasDoctor.com Inc. and Affiliated Research Centers Inc. announced today that the companies have merged, establishing the first Internet healthcare company to significantly impact the pharmaceutical industry's development of new medicines and therapies.

The new organization will offer business-to-business solutions to unmet research and development needs of the pharmaceutical and contract research organization (CRO) industries, as well as solutions to assist research communications, improve new drug introduction and market positioning. The merger creates the first dedicated Internet solution to volunteer recruitment for clinical trials, the pharmaceutical industry's No. 1 obstacle in getting its products to the marketplace.

The AmericasDoctor.com/Affiliated Research Centers merger is an industry landmark, representing the first time a consumer-oriented Internet entity and a clinical trials management organization have combined resources on a large scale to meet a common objective. Pharmaceutical industry estimates show that a delay in bringing a product to market results in the loss of more than $1 million in revenues each day.

The new "clicks and mortar" organization also represents an early entry into the next generation of Internet healthcare companies, whose business strategy from inception integrates a traditional healthcare entity with the strengths of the Internet. The result offers a revolution in e-research and the role of the Internet to position, promote and develop new pharmaceuticals.

Also announced today, Galen Associates Inc., a leading late-stage healthcare venture group based in New York, has led the new company's initial $16 million investment round. Other venture
'"/>


9-Jan-2000


Page: 1 2 3

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Research offers hope of new treatments for liver damage
3. Research suggests possible blood test for multiple sclerosis
4. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
5. 2005 Award for Basic Research in Biological Mineralization
6. 2005 Craniofacial Biology Research Award
7. 2005 Research in Dental Caries Award
8. 2005 Research in Prosthodontics and Implants Award
9. 2005 Basic Research in Periodontal Disease Award
10. 2005 Research in Oral Biology Award
11. 2005 Pulp Biology Research Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... June 23, 2017 , ... ... the launch of Care Management Alerts and Dashboards, an innovative new service enabling ... Island. , RIQI’s Care Management Alerts and Dashboards provide near real-time data about ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids ... risk of visual loss in these patients. , But how often do ophthalmologists and ... cessation to patients at risk of or with early symptoms of AMD? A ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... Everybody has ... it while others prefer to read it, and some people don't like it at ... pornography. Here's what they found: , Erotic literature can give readers a taste of ...
(Date:6/23/2017)... ... 2017 , ... Georgia State University will host the First ... two-day conference is focused on advancing scientific knowledge about the aggressive triple negative ... racial breast cancer-related disparities. The conference theme is “Illuminating Actionable Biology.” , Conference ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ross Insurance Agency ( ... Federal Emergency Management Agency’s (FEMA) recent update of flood zones, more people than ... Biggert-Waters Act was enacted to reflect the actual risk in flood zone areas ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... , June 8, 2017  Less than a month ... more than 200,000 companies, including hospital networks, in over ... as one of the largest online extortion attempts ever ... healthcare market, it is imperative that providers understand where ... data from this — and many other very real ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... two Phase 2 trials of its RSV F protein recombinant ... bearing age have been published in the journal ... been shared in prior scientific conferences). The Company previously announced ... 2014. Novavax is developing the RSV F Vaccine with the ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology:
Cached News: